A recent groundbreaking study has unveiled the intricate workings of a beneficia...
Certain health conditions experienced by mothers during pregnancy have long been...
Enhertu, the first antibody-drug conjugate (ADC) developed by AstraZeneca and Da...
Versant Ventures established Helicore Biopharma exactly two months after establi...
Atalanta Therapeutics has raised $97 million in a successful Series B financing ...
Leap Therapeutics has decided to redirect its efforts towards colorectal cancer ...
A proposed ban on PFAS chemicals is being challenged over concerns about potenti...
The FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-...
A year after reducing half of its workforce, Allakos will downsize to just 15 em...
Acellera and Psivant have announced a strategic research partnership aimed at de...
The potential secretary for Health and Human Services has been forced to defend ...
Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its...
Enhertu is projected to reach $13.9bn in sales by 2030, according to GlobalData’...
The deal includes an upfront payment of $250m, with the potential for an additio...
The approval solidifies Novo Nordisk’s Ozempic as the most broadly indicated GLP...
Sonnet BioTherapeutics has received a patent from the European Patent Office (EP...
